Silicon Labs CAO granted 3,153 RSUs

Silicon Laboratories’ Chief Accounting Officer Mark D. Mauldin reported routine equity compensation changes.

Rhea-AI Filing Summary

Silicon Laboratories’ Chief Accounting Officer Mark D. Mauldin reported routine equity compensation changes. On February 15, 2026, he acquired 3,153 restricted stock units (RSUs) at $0 per share, which will vest in three equal annual installments under the company’s 2009 Stock Incentive Plan.

On February 13, 2026, 356 shares of common stock at $207.27 per share were disposed of to cover taxes upon vesting of a prior award. Following these transactions, he directly beneficially owned 21,930 shares of Silicon Laboratories common stock.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider MAULDIN MARK D

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.0001 par value	3,153	$0.00	$0.00
Exercise Price or Tax Liability	Common Stock, $0.0001 par value	356	$207.27	$74K

Holdings After Transaction: Common Stock, $0.0001 par value — 21,930 shares (Direct)

Footnotes (2)

1. F1. Represents shares withheld to pay taxes upon the vesting of a previously reported equity award.
2. F2. Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of common stock per RSU. One-third of the RSUs will vest on each of the first three anniversaries of the date of grant, and will be settled pursuant to the terms of the Issuer's 2009 Stock Incentive Plan (as amended from time to time).

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Silicon Laboratories (SLAB) report for Mark D. Mauldin?

Mark D. Mauldin reported two transactions: a grant of 3,153 RSUs on February 15, 2026, and a tax-withholding disposition of 356 shares on February 13, 2026, both involving Silicon Laboratories common stock.

How many Silicon Laboratories (SLAB) shares does Mark D. Mauldin own after these Form 4 transactions?

After the reported transactions, Mark D. Mauldin directly beneficially owned 21,930 shares of Silicon Laboratories common stock, reflecting his updated holdings following the RSU grant and the tax-related share withholding disposition.

What was the nature of the 356-share disposition reported by Silicon Laboratories (SLAB)?

The 356-share disposition on February 13, 2026, was coded “F,” meaning shares were withheld to pay taxes upon vesting of a previously reported equity award, rather than an open-market sale by Mark D. Mauldin.

What are the terms of the 3,153 RSUs granted to the Silicon Laboratories (SLAB) CAO?

The 3,153 RSUs granted on February 15, 2026, vest in three equal parts. One-third vests on each of the first three anniversaries of the grant date under Silicon Laboratories’ 2009 Stock Incentive Plan.

At what price were the RSUs and withheld shares recorded for Silicon Laboratories (SLAB)?

The RSU grant to Mark D. Mauldin was recorded at $0 per share, typical for equity awards. The 356 shares withheld for taxes were valued at $207.27 per share in the Form 4 disclosure.

What position does Mark D. Mauldin hold at Silicon Laboratories (SLAB)?

Mark D. Mauldin is identified as the Chief Accounting Officer of Silicon Laboratories Inc. in the Form 4, and the reported equity transactions relate to his role as an officer of the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/17/2026 - 01:15 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MAULDIN MARK D

(Last) (First) (Middle)

400 WEST CESAR CHAVEZ

(Street)

AUSTIN TX 78701

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
SILICON LABORATORIES INC. [ SLAB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value	02/13/2026		F		356(1)	D	$207.27	18,777	D
Common Stock, $0.0001 par value	02/15/2026		A		3,153(2)	A	$0	21,930	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares withheld to pay taxes upon the vesting of a previously reported equity award.

2. Reflects the grant of restricted stock units (RSUs) that will entitle Reporting Person to receive one (1) share of common stock per RSU. One-third of the RSUs will vest on each of the first three anniversaries of the date of grant, and will be settled pursuant to the terms of the Issuer's 2009 Stock Incentive Plan (as amended from time to time).

Remarks:

	Saie-Yau Hui for Mark D Mauldin	02/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.